Recent Updates
Recently added Catalysts
LNTH Negative Sentiment Score: 25/100

LANTHEUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Lantheus Holdings, Inc. on Behalf of Lantheus Stockholders and Encourages Investors to Contact the Firm

Key Takeaway: Bragar Eagel & Squire, P.C. is investigating Lantheus Holdings, Inc. on behalf of stockholders who may have suffered losses. The investigation follows Lantheus's announcement of disappointing second quarter results, which included lower-than-expected earnings and revenue. Additionally, the company reduced its full-year revenue and earnings guidance significantly. As a result, Lantheus's stock price dropped by 28.58% after the news was released.

Market Sentiment Analysis

CONCERNS & RISKS

  • Lantheus announced disappointing second quarter 2025 results, missing EPS and revenue expectations.
  • The company lowered its full year 2025 revenue and EPS guidance significantly.
  • Stock price fell 28.58% following the disappointing earnings announcement.
  • Intensified pricing pressure in the PSMA PET market was cited as a concern.

Full Press Release Details

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Lantheus (LNTH) To Contact Him Directly To Discuss Their Options
If you purchased or acquired stock in Lantheus and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) on behalf of Lantheus stockholders. Our investigation concerns whether Lantheus has violated the federal securities laws and/or engaged in other unlawful business practices.
Click here to participate in the action.
On August 6, 2025, Lantheus announced disappointing second quarter 2025 results, revealing earnings-per-share ("EPS") and revenue figures that missed expectations. In addition, the Company lowered its full year 2025 revenue guidance from $1.550 billion - $1.585 billion to $1.475 billion - $1.51 billion and its full year 2025 adjusted fully diluted EPS guidance from $6.60 - $6.70 per share to $5.50 - $5.70 per share. During an earnings call held that same day, Lantheus's Chief Executive Officer cited intensified pricing pressure in the PSMA PET market and a conscious decision to walk away from volume at certain accounts to protect long-term franchise value. In addition, the Company's Chief Financial Officer stated that "consolidated net revenue for the second quarter was $378 million, a decrease of 4.1%. Radiopharmaceutical oncology currently PYLARIFY contributed $250.6 million of sales, down 8.3%, lower than previously expected."
On this news, Lantheus's stock price fell $20.76 per share, or 28.58%, to close at $51.87 per share on August 6, 2025.
If you purchased or otherwise acquired Lantheus shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X.
Contact Information:
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.

Tags

Bragar Eagel & Squire

Frequently Asked Questions

Who should I contact if I lost money in Lantheus?

Contact Brandon Walker or Marion Passmore at Bragar Eagel & Squire.

What legal issues is Lantheus being investigated for?

Lantheus is under investigation for potential federal securities law violations.

What caused Lantheus's stock price to drop?

The stock fell after Lantheus reported disappointing Q2 results and lowered guidance.

Is there a cost to discuss my claims with Bragar Eagel & Squire?

There is no cost or obligation to discuss your legal rights.

Where can I find more information about Bragar Eagel & Squire?

Visit their website at www.bespc.com for more information.

Last updated: Aug 25, 2025